new york reuters us house democrats say thursday -PRON- launch investigation price multiple sclerosis ms treatment nearly quintuple since 2004 -PRON- send letter request information seven drugmaker
-PRON-
representative elijah cumming peter welch send letter bayer ag biogen inc merck kgaa â€™s emd serono unit novartis ag roche holding ag sanofi sa teva pharmaceutical industries inc
lawmaker us house committee oversight government reform say letter -PRON- look determine whether drug company raise price ms drug lockstep -PRON- competitor
average annual cost ms therapy rise 78000 2016 16000 2004 accord national multiple sclerosis society
drugmaker face global pushback regulator lawmaker high price
president donald trump say company " get away murder " pledge lower cost prescription drug
-PRON- meet representative cumming discuss issue march
previous congressional investigation hearing drug pricing practice farreache effect
mylan nv sharply reduce cost epipen oversight committee begin look increase drive list price life save allergy treatment around 600 pair
valeant pharmaceutical international turing pharmaceutical also face congressional pressure high price
roche say -PRON- plan work lawmaker address -PRON- question say industry need reverse trend sharp increase ms drug price
-PRON- say -PRON- treatment ocrevus price around 20 percent current average cost treatment plan aggressively raise -PRON- price
bayer spokeswoman say company receive letter plan reply directly congress member
novartis say -PRON- review letter determine address request
sanofi immediately comment probe
biogen emd serono teva pharmaceutical industries inc could immediately reach comment